ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,000 | -50.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,000 | +100.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,000 | -50.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,000 | +100.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |